--- title: "Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine" ocid: "ocds-r6ebe6-0000510037" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000510037" markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000510037.md" json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000510037.json" source: "Public Contracts Scotland" current_stage: "Award" buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"THE AUTHORITY\")" published: "2018-02-16" --- # Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") Current stage: Award OCID: ocds-r6ebe6-0000510037 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000510037) [Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000510037.json) ## Summary The procurement process is led by The Common Services Agency, also known as NHS National Services Scotland, for the framework agreement titled "Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine." This procurement falls within the health industry category and is located in Edinburgh, UK. The process is currently at the Award stage, following the open procurement method, with the tender period having ended on 3rd October 2017. An estimated contract value is £30,788,325, covering various lots intended for supply to Health Boards across NHS Scotland. This tender presents substantial opportunities for businesses involved in the pharmaceutical sector, particularly those specialising in analgesics and anaesthetic products. Companies that manufacture or supply generic medicines, particularly those compliant with the relevant UK and European regulations, will be well-suited to compete for the contracts. Given the segmented lots, there is potential for multiple suppliers to be awarded, thereby increasing the scope for small to medium-sized enterprises, as well as larger pharmaceutical companies, to engage in this lucrative framework agreement. ## Notice This Framework Agreement is for the supply of Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to Health Boards across NHS Scotland. The Framework Agreement was awarded in the eighteen (18) Lots listed in this notice ### Lot Information Lot 2 Oxycodone Injections The Supply of Oxycodone Injections to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single supplier. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 1 Baclofen Intrathecal Injections Supply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single supplier. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 4 Oxycodone Hydrochloride Prolonged Release Tablets The Supply of Oxycodone Hydrochloride Prolonged Release Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 5 Buprenorphine Patches The supply of Buprenorphine Patches to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire Lot 6 Fentanyl Tablets (Sublingual) The Supply of Fentanyl Tablets (Sublingual) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire Lot 7 Fentanyl Sf Tablet (Buccal) Supply of Fentanyl Sf Tablets(Buccal) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 8 - Fentanyl Transdermal Patch Supply of Fentanyl Transdermal Patch to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 9 - Hydromorphone Capsule Supply of Hydromorphone Capsule to NHS Scotland in a range of presentations. The Authority intends awarding each product lines as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire Lot 10 - Lidocaine Chlorhexidine Gel Supply of Lidocaine Chlorhexidine Gel to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 11 - Morphine Sulfate Modified-Release capsule (12Hr) Supply of Morphine Sulfate Modified-Release capsule (12hr) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 12 - Morphine Sulfate Modified-Release capsule (24Hr) The Supply of Morphine Sulfate Modified-Release capsule (24Hr) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 13 - Morphine Sulfate Modified-Release Tablet The Supply of Morphine Sulfate Modified-Release Tablet to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 14 - Oxycodone Hydrochloride Capsule The Supply of Oxycodone Hydrochloride Capsule to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 15 - Propofol Injection The Supply of Propofol Injection to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 16 - Tramadol Hydrochloride Modified Release Tablet The Supply of Tramadol Hydrochloride Modified Release Tablet to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 17 - Oxycodone Oral Solution The Supply of Oxycodone Oral Solution to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 18 - All Other Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines Supply of all other Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine in a range of presentations. The Authority intends awarding each line within this Lot to a single supplier. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 3 Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection The Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single supplier. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. ## Key Details | Field | Value | | --- | --- | | Publication source | Public Contracts Scotland | | Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB310681 | | Notice type | OJEU - F3 - Contract Award Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 16 Feb 2018 | | Submission deadline | 3 Oct 2017 | | Future notice date | Not specified | | Award date | 22 Dec 2017 | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £30,788,325 | | Lots value | £30,788,319 | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Complete | | Awards status | Not specified | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") | | Locality | EDINBURGH | | Post town | Edinburgh | | Postcode | EH12 9EB | | Country | Scotland | | ITL 1 | TLM Scotland | | ITL 2 | TLM1 East Central Scotland | | ITL 3 | TLM13 City of Edinburgh | | Local authority | City of Edinburgh | | Electoral ward | Drum Brae/Gyle | | Westminster constituency | Edinburgh South West | | Delivery location | TLM Scotland | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 16 Feb 2018 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB310681 - 1 Sep 2017 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP294282 ## Documents - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP294282 Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine - Supply of Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to Health Boards across NHS Scotland. - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB310681 Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine - This Framework Agreement is for the supply of Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to Health Boards across NHS Scotland. The Framework Agreement was awarded in the eighteen (18) Lots listed in this notice ## Notice URLs - http:// - http://www.nhsscotlandprocurement.scot.nhs.uk/ - http://www.publictendersscotland.publiccontractsscotland.gov.uk - https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000510037 - https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000510037. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000510037.json.